Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

26. Juni 2023 09:00 ET | Quelle: Sermonix Pharmaceuticals Inc.

Sermonix Pharmaceuticals Announces Article Comparing ‘Traditional’ to ‘Just-in-Time’ Trial Enrollment Models Is Published in JCO Clinical Cancer Informatics

Sermonix used the Tempus TIME Trial® Network to enroll 45% of its ELAINE-2 patientsThe company is again partnering with Tempus to enroll patients in its Phase 3 ELAINE-3 study COLUMBUS, Ohio, June ...
26. Juni 2023 08:30 ET | Quelle: Artelo Biosciences

Artelo Biosciences Reports Superior Preclinical Pharmaceutical Properties and Efficacy of ART12.11 Compared to Cannabidiol (CBD) at the 33rd Annual International Cannabinoid Research Society Symposium

ART12.11, a novel and patented cocrystal of CBD reverses the impact of chronic stress on outcomes of anxiety, depression, sociability and cognition ART12.11 aims to address unmet needs within the...
26. Juni 2023 08:15 ET | Quelle: Panbela Therapeutics, Inc.

Panbela Announces Poster Presentation at the Endocrine Society Meeting: Polyamine Inhibition and β-Cell Preservation in Recent Onset Type 1 Diabetes

MINNEAPOLIS, June 26, 2023 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients...
26. Juni 2023 08:00 ET | Quelle: LianBio

LianBio Announces Marketing Approval of CAMZYOS® (mavacamten) in Singapore

SHANGHAI, China and PRINCETON, N.J., June 26, 2023 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other Asian...
26. Juni 2023 07:00 ET | Quelle: Trevena, Inc.

Trevena Announces New Topline OLINVYK Data Highlighting Reduced Cost per Admission from ARTEMIS Real-World Outcomes Study

OLINVYK-treated patients (n=201) had a statistically significant ~$8,750 (19%) lower cost per admission and ~1.4 day (20%) reduced average length of hospital stay, compared to matched patients treated...
26. Juni 2023 06:43 ET | Quelle: Research and Markets

Global Dermal Fillers Report 2023 - Market Predicted to Grow to $10.3 Billion by 2029

Dublin, June 26, 2023 (GLOBE NEWSWIRE) -- The "Global Dermal Fillers Market Size, Share & Industry Trends Analysis Report By Type, By Product, By End-use (MedSpa, Cosmetic Surgery Clinics and...
26. Juni 2023 03:00 ET | Quelle: Janssen Pharmaceutica NV

Janssen Submits Marketing Authorisation Application to the European Medicines Agency (EMA) Seeking Approval of Single Tablet Combination Therapy (STCT) of Macitentan and Tadalafil for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)

This is the first and only single tablet combination therapy to be submitted for review in Europe for this rare, progressive disease If approved, Janssen’s comprehensive PAH portfolio has the...
26. Juni 2023 00:39 ET | Quelle: Proficient Market Insights

Global Hing (Asafoetida) Market (2023 to 2030) - Key Players Include MVM Asafoetida, Anu Foods, G P And Company, S.S.PANDIAN & SONS

PUNE, June 26, 2023 (GLOBE NEWSWIRE) -- "Hing (Asafoetida) Market" | End User (Cooking, Others), Types (Hing Kabuli Sufaid (Milky white asafoetida), Hing Lal (Red asafoetida)), with United States,...
25. Juni 2023 23:52 ET | Quelle: Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Stem, Inc. f/k/a Star Peak Energy Transition Corp. of Class Action Lawsuit and Upcoming Deadline – STEM; STEM.WS; STPK; STPK.WS; STPK.U

NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Stem, Inc. (“Stem” or the “Company”) f/k/a Star Peak Energy Transition Corp....
25. Juni 2023 22:40 ET | Quelle: Pomerantz LLP

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Canopy Growth Corporation of Class Action Lawsuit and Upcoming Deadline – CGC

NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Canopy Growth Corporation (“Canopy Growth” or the “Company”) (NASDAQ: CGC), and...

Vorherige Seite

Nächste Seite